vaccines

Caught in a standoff with its contract manufacturer over Covid-19 vaccine, Inovio files suit in an attempt to break free while rivals race ahead
Caught in a standoff with its contract manufacturer over Covid-19 vaccine, Inovio files suit in an attempt to break free while rivals race ahead
Endpoints
Inovio
vaccines
COVID-19
VGXI
Flag link:
Europe mulls BARDA-style development contracts for COVID-19 vaccines: Bloomberg
Europe mulls BARDA-style development contracts for COVID-19 vaccines: Bloomberg
Fierce Pharma
Europe
vaccines
BARDA
COVID-19
Flag link:
Why Didn't Novavax Make Trump's Top 5 COVID-19 Vaccine List?
Why Didn't Novavax Make Trump's Top 5 COVID-19 Vaccine List?
Motley Fool
Donald Trump
Operation Warp Speed
vaccines
COVID-19
Novavax
Flag link:
Report: Trump Administration Picks 5 Coronavirus Vaccine Candidates to Support
Report: Trump Administration Picks 5 Coronavirus Vaccine Candidates to Support
Motley Fool
vaccines
Donald Trump
Operation Warp Speed
COVID-19
Moderna Therapeutics
JNJ
Merck
Pfizer
AstraZeneca
BioNTech
Flag link:
Why Sorrento Therapeutics Shares Are Tumbling Today
Why Sorrento Therapeutics Shares Are Tumbling Today
Motley Fool
vaccines
Sorrento Therapeutics
Anthony Fauci
NIAID
COVID-19
Flag link:
Codiak BioSciences collaborates with Ragon Institute to evaluate exoVACC vaccine platform in SARS-CoV-2 and HIV
Codiak BioSciences collaborates with Ragon Institute to evaluate exoVACC vaccine platform in SARS-CoV-2 and HIV
Pharmaceutical Business Review
Codiak Biosciences
COVID-19
Ragon Institute
vaccines
Flag link:
Fauci: Moderna’s Phase 3 Covid-19 Vaccine Trial Of 30,000 Individuals Will Begin In July
Fauci: Moderna’s Phase 3 Covid-19 Vaccine Trial Of 30,000 Individuals Will Begin In July
Forbes
Anthony Fauci
Moderna Therapeutics
vaccines
COVID-19
clinical trials
Flag link:
US government promises Maryland drug manufacturer $628M to make coronavirus vaccines
US government promises Maryland drug manufacturer $628M to make coronavirus vaccines
BioPharma Dive
federal government
Emergent BioSolutions
vaccines
COVID-19
grants
Flag link:
Are Moderna’s Coronavirus Gains Over?
Are Moderna’s Coronavirus Gains Over?
Motley Fool
Moderna Therapeutics
vaccines
COVID-19
Novavax
Flag link:
Here's the Under-the-Radar Biotech That Could Beat Moderna at Its Own Game
Here's the Under-the-Radar Biotech That Could Beat Moderna at Its Own Game
Motley Fool
Moderna Therapeutics
vaccines
COVID-19
BioNTech
MRNA
Flag link:
Why Moderna Stock Jumped 10.7% Friday
Why Moderna Stock Jumped 10.7% Friday
Motley Fool
Moderna Therapeutics
COVID-19
vaccines
clinical trials
mRNA-1273
Flag link:
Sanofi loses vaccines chief Loew to Ipsen amid global attention on its COVID-19 project
Sanofi loses vaccines chief Loew to Ipsen amid global attention on its COVID-19 project
Fierce Pharma
Sanofi
Paul Hudson
David Loew
Ipsen
Pharma CEOs
FerGene
vaccines
Flag link:
Facing vial shortage, pharmas explore workarounds for coronavirus vaccines
Facing vial shortage, pharmas explore workarounds for coronavirus vaccines
BioPharma Dive
vaccines
pandemic
vials
COVID-19
Flag link:
Pharma leaders shoot down WHO voluntary pool for patent rights on Covid-19 products
Pharma leaders shoot down WHO voluntary pool for patent rights on Covid-19 products
Stat
WHO
patents
COVID-18
vaccines
diagnostics
Flag link:
GlaxoSmithKline aims to make 1B doses of vaccine booster for multiple COVID-19 partners
GlaxoSmithKline aims to make 1B doses of vaccine booster for multiple COVID-19 partners
Fierce Pharma
GSK
vaccines
COVID-19
drug manufacturing
Sanofi
pandemic
Flag link:
AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica production deal
AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica production deal
Fierce Pharma
AstraZeneca
University of Oxford
vaccines
COVID-19
pandemic
drug manufacturing
Flag link:
Novavax Makes a $167 Million Purchase to Boost Its Coronavirus Vaccine Production Capacity
Novavax Makes a $167 Million Purchase to Boost Its Coronavirus Vaccine Production Capacity
Motley Fool
Novavax
vaccines
drug manufacturing
M&A
COVID-19
Praha Vaccines
Flag link:
U.S. is ahead of China in vaccine race, former FDA chief says
U.S. is ahead of China in vaccine race, former FDA chief says
Politico
China
vaccines
COVID-19
drug development
Scott Gottlieb
Flag link:
Poll: 60% Of US Adults Plan To Get Flu Vaccine, Now Pharmacies Are Preparing For A Rush
Poll: 60% Of US Adults Plan To Get Flu Vaccine, Now Pharmacies Are Preparing For A Rush
Forbes
vaccines
Flu
flu vaccines
influenza
COVID-19
pandemic
Flag link:
Merck leaps into Covid-19 vaccine race, aiming to test two different candidates this year
Merck leaps into Covid-19 vaccine race, aiming to test two different candidates this year
Stat
Merck
vaccines
COVID-19
Flag link:

Pages